118 related articles for article (PubMed ID: 6422854)
1. Calmodulin and parvalbumin: activators of human liver glucocerebrosidase.
Glew RH; Coffee CJ
Arch Biochem Biophys; 1984 Feb; 229(1):55-63. PubMed ID: 6422854
[TBL] [Abstract][Full Text] [Related]
2. Activators of spleen glucocerebrosidase from controls and patients with various forms of Gaucher's disease.
Basu A; Glew RH; Daniels LB; Clark LS
J Biol Chem; 1984 Feb; 259(3):1714-9. PubMed ID: 6693432
[TBL] [Abstract][Full Text] [Related]
3. Further studies on the activation of glucocerebrosidase by a heat-stable factor from Gaucher spleen.
Prence E; Chakravorti S; Basu A; Clark LS; Glew RH; Chambers JA
Arch Biochem Biophys; 1985 Jan; 236(1):98-109. PubMed ID: 3966805
[TBL] [Abstract][Full Text] [Related]
4. Sulfogalactocerebroside and bis-(monoacylglyceryl)-phosphate as activators of spleen glucocerebrosidase.
Prence EM; Garrett KO; Panitch H; Basu A; Glew RH; Wherrett JR; Huterer S
Clin Chim Acta; 1986 Apr; 156(2):179-89. PubMed ID: 3085988
[TBL] [Abstract][Full Text] [Related]
5. Comparison of N-acyl phosphatidylethanolamines with different N-acyl groups as activators of glucocerebrosidase in various forms of Gaucher's disease.
Basu A; Prence E; Garrett K; Glew RH; Ellingson JS
Arch Biochem Biophys; 1985 Nov; 243(1):28-34. PubMed ID: 3933429
[TBL] [Abstract][Full Text] [Related]
6. Purification and properties of a heat-stable glucocerebrosidase activating factor from control and Gaucher spleen.
Peters SP; Coyle P; Coffee CJ; Glew RH
J Biol Chem; 1977 Jan; 252(2):563-73. PubMed ID: 13071
[TBL] [Abstract][Full Text] [Related]
7. Activation of human spleen glucocerebrosidases by monoacylglycol sulfates and diacylglycerol sulfates.
Gonzales ML; Basu A; de Haas GH; Dijkman R; van Oort MG; Okolo AA; Glew RH
Arch Biochem Biophys; 1988 Apr; 262(1):345-53. PubMed ID: 3355173
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the phospholipid requirement of a rat liver beta-glucosidase.
Basu A; Glew RH
Biochem J; 1984 Dec; 224(2):515-24. PubMed ID: 6517862
[TBL] [Abstract][Full Text] [Related]
9. Gaucher disease: the effects of phosphatidylserine on glucocerebrosidase from normal and Gaucher fibroblasts.
Choy FY
Hum Genet; 1984; 67(4):432-6. PubMed ID: 6436168
[TBL] [Abstract][Full Text] [Related]
10. A kinetic study of the effects of galactocerebroside 3-sulphate on human spleen glucocerebrosidase. Evidence for two activator-binding sites.
Prence EM; Garrett KO; Glew RH
Biochem J; 1986 Aug; 237(3):655-62. PubMed ID: 3800908
[TBL] [Abstract][Full Text] [Related]
11. Isolation of heat-stable glucocerebrosidase activators from the spleens of three variants of Gaucher's disease.
Peters SP; Coffee CJ; Glew RH; Lee RE; Wenger DA; Li SC; Li YT
Arch Biochem Biophys; 1977 Sep; 183(1):290-7. PubMed ID: 907355
[No Abstract] [Full Text] [Related]
12. Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease.
Glew RH; Daniels LB; Clark LS; Hoyer SW
J Neuropathol Exp Neurol; 1982 Nov; 41(6):630-41. PubMed ID: 6813430
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the ability of phospholipids from rat liver lysosomes to reconstitute glucocerebrosidase.
Basu A; Glew RH; Wherrett JR; Huterer S
Arch Biochem Biophys; 1986 Mar; 245(2):464-9. PubMed ID: 3954363
[TBL] [Abstract][Full Text] [Related]
14. Gaucher disease: isolation and comparison of normal and mutant glucocerebrosidase from human spleen tissue.
Pentchev PG; Brady RO; Blair HE; Britton DE; Sorrell SH
Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3970-3. PubMed ID: 29293
[TBL] [Abstract][Full Text] [Related]
15. Sucrose gradient analysis of phospholipid-activated beta-glucosidase in type 1 and type 2 Gaucher's disease.
Garrett KO; Prence EM; Glew RH
Arch Biochem Biophys; 1985 Apr; 238(1):344-52. PubMed ID: 3920967
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the catalytic subunit of cyclic AMP-dependent protein kinase by calmodulin, S-100 protein, parvalbumin and troponin.
Kuo WN; Dominguez JL; Shabazz KA; White DJ; Nicholson J; Puente K; Shells P; Redding C; Blake T; Sen S
Cytobios; 1986; 46(186-187):139-46. PubMed ID: 3743131
[TBL] [Abstract][Full Text] [Related]
17. Comparative study on glucocerebrosidase in spleens from patients with Gaucher disease.
Aerts JM; Donker-Koopman WE; Brul S; Van Weely S; Sa Miranda MC; Barranger JA; Tager JM; Schram AW
Biochem J; 1990 Jul; 269(1):93-100. PubMed ID: 2198026
[TBL] [Abstract][Full Text] [Related]
18. A revised fluorometric assay for Gaucher's disease using conduritol-beta-epoxide with liver as the source of Beta-glucosidase.
Daniels LB; Glew RH; Radin NS; Vunnam RR
Clin Chim Acta; 1980 Sep; 106(2):155-63. PubMed ID: 6773704
[TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of a cytosolic broad specificity beta-glucosidase from human liver.
Daniels LB; Coyle PJ; Chiao YB; Glew RH; Labow RS
J Biol Chem; 1981 Dec; 256(24):13004-13. PubMed ID: 6796580
[TBL] [Abstract][Full Text] [Related]
20. Conditions affecting the activity of glucocerebrosidase purified from spleens of control subjects and patients with type 1 Gaucher disease.
Aerts JM; Sa Miranda MC; Brouwer-Kelder EM; Van Weely S; Barranger JA; Tager JM
Biochim Biophys Acta; 1990 Oct; 1041(1):55-63. PubMed ID: 2223847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
